| human | Q5 |
| P496 | ORCID iD | 0000-0001-7076-3714 |
| P108 | employer | University of Würzburg | Q161976 |
| P734 | family name | Kraft | Q10548439 |
| Kraft | Q10548439 | ||
| Kraft | Q10548439 | ||
| P735 | given name | Peter | Q2793400 |
| Peter | Q2793400 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q36332351 | Adherence to oral anticoagulant therapy in secondary stroke prevention - impact of the novel oral anticoagulants |
| Q38791637 | Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection |
| Q92754476 | Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-Updated series of 120 cases |
| Q38415781 | Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. |
| Q48515766 | Antithrombotic potential of blockers of store-operated calcium channels in platelets. |
| Q90588245 | Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage |
| Q41854019 | B cells do not have a major pathophysiologic role in acute ischemic stroke in mice. |
| Q48356905 | Blocking of plasma kallikrein ameliorates stroke by reducing thromboinflammation |
| Q37597099 | Blocking of platelet glycoprotein receptor Ib reduces "thrombo-inflammation" in mice with acute ischemic stroke. |
| Q51740914 | Blocking of α4 integrin does not protect from acute ischemic stroke in mice |
| Q36919773 | Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells |
| Q48457296 | C1-inhibitor protects from brain ischemia-reperfusion injury by combined antiinflammatory and antithrombotic mechanisms. |
| Q41701185 | CD28 superagonist-mediated boost of regulatory T cells increases thrombo-inflammation and ischemic neurodegeneration during the acute phase of experimental stroke. |
| Q98228942 | CD84 Links T Cell and Platelet Activity in Cerebral Thrombo-Inflammation in Acute Stroke |
| Q39392693 | COU254, a specific 3-carboxamide-coumarin inhibitor of coagulation factor XII, does not protect mice from acute ischemic stroke |
| Q35154663 | Case-control study of platelet glycoprotein receptor Ib and IIb/IIIa expression in patients with acute and chronic cerebrovascular disease. |
| Q34253359 | Categorization of multiple sclerosis relapse subtypes by B cell profiling in the blood |
| Q92046626 | Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage |
| Q36247545 | Characterization of Peripheral Immune Cell Subsets in Patients with Acute and Chronic Cerebrovascular Disease: A Case-Control Study |
| Q38384045 | Coagulation Testing in Acute Ischemic Stroke Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants |
| Q89051120 | Cognitive Deficits and Related Brain Lesions in Patients With Chronic Heart Failure |
| Q90336098 | Corrigendum to 'Should IV Thrombolysis be given in Patients with Suspected Ischemic Stroke but Unknown Symptom Onset and Without Diffusion-Weighted Imaging Lesion? - Results of a Case-Control Study' [Journal of Stroke and Cerebrovascular Diseases, V |
| Q48733749 | Dabigatran Etexilate Reduces Thrombin-Induced Inflammation and Thrombus Formation in Experimental Ischemic Stroke. |
| Q33769511 | Deficiency of Vasodilator-Stimulated Phosphoprotein (VASP) Increases Blood-Brain-Barrier Damage and Edema Formation after Ischemic Stroke in Mice |
| Q47690322 | Depletion of CD11c+ Cells Does Not Influence Outcomes in Mice Subjected to Transient Middle Cerebral Artery Occlusion |
| Q90632684 | Description of a Novel Phosphodiesterase (PDE)-3 Inhibitor Protecting Mice From Ischemic Stroke Independent From Platelet Function |
| Q45331616 | Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation |
| Q52147721 | Efficacy and Safety of Platelet Glycoprotein Receptor Blockade in Aged and Comorbid Mice With Acute Experimental Stroke |
| Q49040217 | FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection |
| Q40085872 | Feasibility and diagnostic accuracy of point-of-care handheld echocardiography in acute ischemic stroke patients - a pilot study |
| Q88867158 | Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis |
| Q41890445 | Glatiramer acetate does not protect from acute ischemic stroke in mice. |
| Q39590096 | Glucocorticoid insensitivity at the hypoxic blood-brain barrier can be reversed by inhibition of the proteasome. |
| Q28590644 | Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice. |
| Q37640881 | Haemorrhagic Transformation after Ischaemic Stroke in Patients Taking Non-vitamin K Antagonist Oral Anticoagulants |
| Q93137496 | Heparin for prophylaxis of venous thromboembolism in intracerebral haemorrhage |
| Q38630400 | Hypercholesterolemia induced cerebral small vessel disease |
| Q36743512 | Immunohistochemical Analysis of Cerebral Thrombi Retrieved by Mechanical Thrombectomy from Patients with Acute Ischemic Stroke. |
| Q100510988 | Immunohistological Analysis of Neutrophils and Neutrophil Extracellular Traps in Human Thrombemboli Causing Acute Ischemic Stroke |
| Q55322373 | Immunotherapy of experimental and human stroke with agents approved for multiple sclerosis: a systematic review. |
| Q50097277 | Influence of Thrombolysis on the Safety and Efficacy of Blocking Platelet Adhesion or Secretory Activity in Acute Ischemic Stroke in Mice |
| Q36528998 | Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation |
| Q90259044 | Loss of Orai2-Mediated Capacitative Ca2+ Entry Is Neuroprotective in Acute Ischemic Stroke |
| Q52807848 | Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves |
| Q26865345 | Next-generation antithrombotics in ischemic stroke: preclinical perspective on 'bleeding-free antithrombosis' |
| Q33407058 | Only severe thrombocytopenia results in bleeding and defective thrombus formation in mice. |
| Q27325578 | Partially Defective Store Operated Calcium Entry and Hem(ITAM) Signaling in Platelets of Serotonin Transporter Deficient Mice |
| Q47978474 | Pharmacological inhibition of phospholipase D protects mice from occlusive thrombus formation and ischemic stroke--brief report |
| Q35644702 | Platelet Gi protein Gαi2 is an essential mediator of thrombo-inflammatory organ damage in mice |
| Q88297293 | Platelet derived FasL contributes to apoptosis in stroke |
| Q48362280 | Platelet secretion is crucial to prevent bleeding in the ischemic brain but not in the inflamed skin or lung in mice |
| Q36070471 | Platelets induce apoptosis via membrane-bound FasL. |
| Q27323209 | Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration |
| Q87875682 | Prescription frequency and predictors for the use of novel direct oral anticoagulants for secondary stroke prevention in the first year after their marketing in Europe--a multicentric evaluation |
| Q52147696 | Pretreatment with rivaroxaban attenuates stroke severity in rats by a dual antithrombotic and anti-inflammatory mechanism. |
| Q104555339 | Prevalence and determinants of systolic and diastolic cardiac dysfunction and heart failure in acute ischemic stroke patients: The SICFAIL study |
| Q38806828 | Prothrombin and factor X are elevated in multiple sclerosis patients. |
| Q33773324 | Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease |
| Q50609395 | Regulation of blood coagulation factors XI and XII in patients with acute and chronic cerebrovascular disease: a case-control study. |
| Q42059906 | Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature |
| Q48409685 | Reliability of infarct volumetry: Its relevance and the improvement by a software-assisted approach |
| Q34802412 | SLAP/SLAP2 prevent excessive platelet (hem)ITAM signaling in thrombosis and ischemic stroke in mice |
| Q91569975 | Should IV Thrombolysis be given in Patients with Suspected Ischemic Stroke but Unknown Symptom Onset and Without Diffusion-Weighted Imaging Lesion? - Results of a Case-Control Study |
| Q47662775 | Stroke-induced chronic systolic dysfunction driven by sympathetic overactivity. |
| Q33869531 | Sustained reperfusion after blockade of glycoprotein-receptor-Ib in focal cerebral ischemia: an MRI study at 17.6 Tesla |
| Q57803226 | Systematic evaluation of stroke thrombectomy in clinical practice: The German Stroke Registry Endovascular Treatment |
| Q47394096 | TRPM7 (Transient Receptor Potential Melastatin-Like 7 Channel) Kinase Controls Calcium Responses in Arterial Thrombosis and Stroke in Mice |
| Q64252291 | Targeting Platelet GPVI Plus rt-PA Administration but Not α2β1-Mediated Collagen Binding Protects against Ischemic Brain Damage in Mice |
| Q38821387 | Telemedical strategies for the improvement of secondary prevention in patients with cerebrovascular events-A systematic review and meta-analysis |
| Q36685376 | The NKG2D-IL-15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathies |
| Q104286743 | The NLRP3 inflammasome drives inflammation in ischemia/reperfusion injury after transient middle cerebral artery occlusion in mice |
| Q50859450 | The Novel Oral Syk Inhibitor, Bl1002494, Protects Mice From Arterial Thrombosis and Thromboinflammatory Brain Infarction |
| Q34660857 | The phosphodiesterase-4 inhibitor rolipram protects from ischemic stroke in mice by reducing blood-brain-barrier damage, inflammation and thrombosis. |
| Q38260269 | The two-pore domain potassium channel KCNK5 deteriorates outcome in ischemic neurodegeneration. |
| Q33640335 | Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice are susceptible to intracerebral thrombosis and ischemic stroke |
| Q90464063 | Two years' experience of implementing a comprehensive telemedical stroke network comprising in mainly rural region: the Transregional Network for Stroke Intervention with Telemedicine (TRANSIT-Stroke) |
| Q92620625 | Validity and Reliability of Neurological Scores in Mice Exposed to Middle Cerebral Artery Occlusion |
| Q33768997 | Von Willebrand factor regulation in patients with acute and chronic cerebrovascular disease: a pilot, case-control study. |
| Q96294294 | [Development of a German telephone version of the IQCODE (The Informant Questionnaire on Cognitive Decline in the Elderly) within a cohort of relatives of ischemic stroke patients] |
Search more.